Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Tarsus Pharmaceuticals (TARS) Interest Coverage Ratio (2022 - 2025)

Historic Interest Coverage Ratio for Tarsus Pharmaceuticals (TARS) over the last 4 years, with Q3 2025 value amounting to 6.41.

  • Tarsus Pharmaceuticals' Interest Coverage Ratio rose 3775.19% to 6.41 in Q3 2025 from the same period last year, while for Sep 2025 it was 9.68, marking a year-over-year increase of 5508.24%. This contributed to the annual value of 15.36 for FY2024, which is 6409.69% up from last year.
  • According to the latest figures from Q3 2025, Tarsus Pharmaceuticals' Interest Coverage Ratio is 6.41, which was up 3775.19% from 9.9 recorded in Q2 2025.
  • Over the past 5 years, Tarsus Pharmaceuticals' Interest Coverage Ratio peaked at 6.41 during Q3 2025, and registered a low of 61.78 during Q1 2022.
  • Over the past 4 years, Tarsus Pharmaceuticals' median Interest Coverage Ratio value was 21.76 (recorded in 2022), while the average stood at 26.79.
  • Its Interest Coverage Ratio has fluctuated over the past 5 years, first crashed by 31936.28% in 2023, then skyrocketed by 7842.96% in 2024.
  • Over the past 4 years, Tarsus Pharmaceuticals' Interest Coverage Ratio (Quarter) stood at 21.76 in 2022, then tumbled by 106.5% to 44.94 in 2023, then soared by 76.5% to 10.56 in 2024, then skyrocketed by 39.35% to 6.41 in 2025.
  • Its last three reported values are 6.41 in Q3 2025, 9.9 for Q2 2025, and 11.88 during Q1 2025.